PT975364E - Formulacao de alergenos - Google Patents

Formulacao de alergenos

Info

Publication number
PT975364E
PT975364E PT98919258T PT98919258T PT975364E PT 975364 E PT975364 E PT 975364E PT 98919258 T PT98919258 T PT 98919258T PT 98919258 T PT98919258 T PT 98919258T PT 975364 E PT975364 E PT 975364E
Authority
PT
Portugal
Prior art keywords
allergen
formulation
Prior art date
Application number
PT98919258T
Other languages
English (en)
Inventor
Jorj Terry Ulrich
Alan Worland Wheeler
Original Assignee
Allergy Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergy Therapeutics Ltd filed Critical Allergy Therapeutics Ltd
Publication of PT975364E publication Critical patent/PT975364E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PT98919258T 1997-04-05 1998-04-03 Formulacao de alergenos PT975364E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9706957.9A GB9706957D0 (en) 1997-04-05 1997-04-05 Formulation

Publications (1)

Publication Number Publication Date
PT975364E true PT975364E (pt) 2004-09-30

Family

ID=10810358

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98919258T PT975364E (pt) 1997-04-05 1998-04-03 Formulacao de alergenos

Country Status (17)

Country Link
US (2) US7718178B2 (pt)
EP (1) EP0975364B1 (pt)
JP (1) JP4331798B2 (pt)
KR (1) KR100549557B1 (pt)
AR (1) AR011707A1 (pt)
AT (1) ATE268607T1 (pt)
AU (1) AU729631B2 (pt)
CA (1) CA2285928C (pt)
CO (1) CO4940482A1 (pt)
DE (1) DE69824405T2 (pt)
ES (1) ES2218819T3 (pt)
GB (1) GB9706957D0 (pt)
NZ (1) NZ337580A (pt)
PT (1) PT975364E (pt)
TW (1) TWI240628B (pt)
WO (1) WO1998044947A1 (pt)
ZA (1) ZA982851B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706957D0 (en) * 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) * 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
GB201106802D0 (en) * 2011-04-21 2011-06-01 Allergy Therapeutics Ltd Process for preparing vaccine composition
CN116199727B (zh) * 2021-12-01 2025-04-08 上海安奕康生物科技有限公司 一种mpl三乙胺盐、其制备工艺及应用

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1128637A (en) 1966-09-13 1968-09-25 Beecham Group Ltd Influenza vaccine
US3541201A (en) * 1968-12-18 1970-11-17 Ethan Alan Brown Novel sodium chloride encapsulated injectionable substances
GB1377074A (en) * 1971-07-13 1974-12-11 Beecham Group Ltd Process for preparing injectable compositions
US4070455A (en) * 1974-02-16 1978-01-24 Beecham Group Limited Process for preparing injectable desensitizing compositions and products thereof in microparticle form
GB1492973A (en) * 1974-02-16 1977-11-23 Beecham Group Ltd Process for preparing injectable compositions
EP0182442B2 (en) 1978-12-22 1996-04-03 Biogen, Inc. Recombinant DNA molecules and their method of production
US4258029A (en) 1979-04-23 1981-03-24 Connaught Laboratories Limited Synthetic adjuvants for stimulation of antigenic responses
US4528029A (en) * 1980-07-21 1985-07-09 Board Of Control Of Michigan Technological University Self-reducing iron oxide agglomerates
US4987237A (en) * 1983-08-26 1991-01-22 Ribi Immunochem Research, Inc. Derivatives of monophosphoryl lipid A
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5244663A (en) * 1987-01-28 1993-09-14 Medibrevex Therapeutic method against allergy
FR2621916B1 (fr) * 1987-10-19 1990-03-09 Bioeurope Derives de la l-tyrosine solubles dans l'eau et procede pour leur preparation
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
GB9106048D0 (en) 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccines
CA2131442A1 (en) 1992-03-03 1993-09-04 Seishi Tsuchiya Oral vaccine
DK0671948T3 (da) * 1992-06-25 1997-09-01 Smithkline Beecham Biolog Vaccinepræparat indeholdende adjuvanser
ATE157882T1 (de) * 1993-03-23 1997-09-15 Smithkline Beecham Biolog 3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
EP0705109B2 (en) 1993-05-25 2004-01-02 American Cyanamid Company Adjuvants for vaccines against respiratory syncytial virus
CA2167691A1 (en) 1993-08-27 1995-03-02 Martin J. Blaser Campylobacter jejuni antigens, and methods for their production and use
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
US5997873A (en) * 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5646115A (en) * 1994-10-07 1997-07-08 Heska Corporation Ectoparasite saliva proteins and apparatus to collect such proteins
AU4977896A (en) 1995-02-17 1996-09-04 Immunotherapy, Inc. Immunotherapy screening, prognosis, and treatment methods and compositions
GB9508785D0 (en) * 1995-04-29 1995-06-21 Smithkline Beecham Plc Novel compositions
US5762943A (en) * 1996-05-14 1998-06-09 Ribi Immunochem Research, Inc. Methods of treating type I hypersensitivity using monophosphoryl lipid A
US5973128A (en) * 1996-11-22 1999-10-26 The Hospital For Sick Children Research And Development Lp Glycolipid mimics and methods of use thereof
NZ338101A (en) 1997-04-01 2002-03-28 Corixa Corp Adjuvant compositions of Monophosphoryl Lipid A (MPL) and a phospholipid based surfactant (1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)) suitable for intranasal administration
US6491919B2 (en) 1997-04-01 2002-12-10 Corixa Corporation Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
GB9706957D0 (en) * 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
AU7983198A (en) 1997-06-23 1999-01-04 Ludwig Institute For Cancer Research Improved methods for inducing an immune response
GB9717953D0 (en) 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine
GB9720585D0 (en) 1997-09-26 1997-11-26 Smithkline Beecham Biolog Vaccine
CA2319380A1 (en) 1997-11-10 1999-05-20 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
GB9812613D0 (en) 1998-06-11 1998-08-12 Smithkline Beecham Biolog Vaccine
CA2330209A1 (en) 1998-06-12 1999-12-23 Smithkline Beecham Biologicals S.A. Recombinant production of toxoplasma sag1 antigen
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
US6734172B2 (en) 1998-11-18 2004-05-11 Pacific Northwest Research Institute Surface receptor antigen vaccines
PT1031347E (pt) 1999-01-27 2002-09-30 Idea Ag Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis
CA2366688A1 (en) 1999-02-26 2000-08-31 Chiron Corporation Use of bioadhesives and adjuvants for the mucosal delivery of antigens
GB9909077D0 (en) 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
TR200103046T2 (tr) 1999-04-23 2002-06-21 Pharmexa A/S IL5 aktivitesini düşürmek için yöntem.
UA81216C2 (en) 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
GB9924529D0 (en) 1999-10-15 1999-12-15 Smithkline Beecham Biolog Novel compounds
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation

Also Published As

Publication number Publication date
EP0975364B1 (en) 2004-06-09
JP2001519797A (ja) 2001-10-23
AU729631B2 (en) 2001-02-08
ES2218819T3 (es) 2004-11-16
US7718178B2 (en) 2010-05-18
TWI240628B (en) 2005-10-01
US20050123570A1 (en) 2005-06-09
WO1998044947A1 (en) 1998-10-15
CO4940482A1 (es) 2000-07-24
US20100183659A1 (en) 2010-07-22
DE69824405D1 (de) 2004-07-15
NZ337580A (en) 2001-04-27
EP0975364A1 (en) 2000-02-02
ATE268607T1 (de) 2004-06-15
GB9706957D0 (en) 1997-05-21
AR011707A1 (es) 2000-08-30
DE69824405T2 (de) 2004-10-07
KR100549557B1 (ko) 2006-02-08
ZA982851B (en) 1999-10-04
US8105605B2 (en) 2012-01-31
KR20010005651A (ko) 2001-01-15
CA2285928C (en) 2008-07-08
CA2285928A1 (en) 1998-10-15
AU7216098A (en) 1998-10-30
JP4331798B2 (ja) 2009-09-16

Similar Documents

Publication Publication Date Title
ID25533A (id) Formulasi 2-metil-tieno-benzodiazepin
ID24654A (id) Formulasi farmasi omeprazola
EP0968223A4 (en) BIOKON JUGATION OF MACROMOLECULES
PT1006792E (pt) Formulacao agroquimica
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
DE69833739D1 (de) Kosmetisches Präparat
DE69838845D1 (de) Zerstäuber
DE69634256D1 (de) Zementformulierung
DE69817706D1 (de) UV-Schutzformulierung
DE69823565D1 (de) Zerstäuber
DE69828330D1 (de) Aktiviertes Protein C Formulierungen
DK0853945T3 (da) Flydende gonadotropinholdige formuleringer
BR9701304A (pt) Formulação de liberação prolongada
MA24473A1 (fr) Formulations
PT1028718E (pt) Formulacao de libertacao prolongada
ATA181095A (de) Probiotisch wirksame formulierung
DK1000079T3 (da) Hidtil ukendt formulering
ID18832A (id) Komposisi insektisida
ID23928A (id) Formulasi mengandung insektisida
DE69837507D1 (de) Humanes Hedgehog-Protein
PT964867E (pt) Antagonistas da taquicinima
PT975364E (pt) Formulacao de alergenos
ID22379A (id) Hidrogenasi imina enamina
NO985079D0 (no) Eksplosiv formulering
ID23774A (id) Komposisi insektisida